Hamada, Yuki
Hirano, Eiichi
Sugimoto, Koji
Hanada, Keizo
Kaku, Taiichi
Manda, Naoki
Tsuchida, Kenichi
Article History
Received: 17 August 2021
Accepted: 14 December 2021
First Online: 23 January 2022
Declarations
:
: Patient consent for the study of their tissues and use of their health data for research purposes was obtained. A copy of the consent form is available upon request.
: Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: Taiichi Kaku is a stockholder of the Japan Bio Products Co. Ltd. Koji Sugimoto, Keizo Hanada, and Eiichi Hirano are employees of the Japan Bio Products Co. Ltd. Yuki Hamada, Naoki Manda, and Kenichi Tsuchida declare that they have no competing interests.